Call Now: +1 858 800 3101 Email: info@innopep.com
| Overview | |
|---|---|
| Description | This is histone H3 (1-21) with deimination of Arg2, Arg8, and Arg17 to Citrulline (Cit). Its C-terminal is biotinylated through a GGK linker and blocked by an amide group. Deimination by peptidyl arginine deiminase 4 (PADI4) prevents methylation at these sites and blocks transcriptional activation. Provided at >95% peptide purity, this peptide was dissolved in distilled water at 1 mg/ml and re-lyophilized to powder form. |
| Sequence | A-Cit-TKQTA-Cit-KSTGGKAP-Cit-KQLAGG-K(Biotin)-NH2 |
| Sequence (3 Letter) | H-Ala-Cit-Thr-Lys-Gln-Thr-Ala-Cit-Lys-Ser-Thr-Gly-Gly-Lys-Ala-Pro-Cit-Lys-Gln-Leu-Ala-Gly-Gly-Lys(Biotin)-NH2 |
| Molecular Weight | 2725.2 |
| Properties | |
| Purity | > 95% By HPLC |
| Storage | Store at -20 °C, cap vial tightly at all times. |
InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.